Emotionally salient information activates orexin neurons in the lateral hypothalamus, leading to increase in sympathetic outflow and vigilance level. How this circuit alters animals’ behavior remains unknown. Here we report that noradrenergic neurons in the locus coeruleus (NALC neurons) projecting to the lateral amygdala (LA) receive synaptic input from orexin neurons. Pharmacogenetic/optogenetic silencing of this circuit as well as acute blockade of the orexin receptor-1 (OX1R) decreases conditioned fear responses. In contrast, optogenetic stimulation of this circuit potentiates freezing behavior against a similar but distinct context or cue. Increase of orexinergic tone by fasting also potentiates freezing behavior and LA activity, which are blocked by pharmacological blockade of OX1R in the LC. These findings demonstrate the circuit involving orexin, NALC and LA neurons mediates fear-related behavior and suggests inappropriate excitation of this pathway may cause fear generalization sometimes seen in psychiatric disorders, such as PTSD.
Learned fear is an adaptive behavioral response that allows animals to predict potential threats based on memory of past aversive experiences. While there are behavioral advantages to the association of aversive experiences previously paired with a distinct stimulus or context to related cues or similar situations, a process known as fear generalization, this ability must be appropriately controlled to be beneficial for an organism. The classical Pavlovian fear conditioning model is well suited to understanding how animals learn stimuli in a particular environment signal threats, and the neuronal mechanisms underlying this function have been extensively studied1,2. However, the neuronal mechanisms as to how fear learning is generalized or modulated to adapt other stimuli that contain similar, but distinct elements of a learned threat remain largely unexplored. Here, we found that orexin plays a role in regulation of the level of fear-related responses in situations that resemble a past aversive experience.
Orexin plays a highly important role in maintenance of arousal3,4. Many studies have suggested that orexin neurons are activated during the behavioral expression of fear or in response to cues associated with danger or reward4. Thus, we hypothesized that this activation might play a role in modulating animal’s appropriate behavior depending on the situation, because orexin is a key molecule in the shift to a “vigilant” state in emotionally arousing situations4. For instance, behavioral and stress responses to intruders and the cardiovascular response to air jet stress were shown to be attenuated in orexin-deficient mice5. Orexin neurons receive input from the bed nucleus of the stria terminalis (BST), suggesting that the limbic system regulates activity of these cells in response to emotionally salient stimuli6,7. We confirmed that orexin neurons were markedly activated by both cued and contextual fear (Supplementary Fig. 1).
We previously reported that noradrenergic neurons in the locus coeruleus (NALC neurons), which abundantly express orexin receptor-1 (OX1R), are involved in the expression and/or consolidation of cued fear memory via an activation of the lateral amygdala (LA) neurons8. These results suggest the potential role of orexin neurons in the recruitment of LA-projecting NALC (NALC→LA) neurons to control expression of fear-related behavior. However, the role of this pathway on the behavioral expression of fear itself, rather than consolidation of fear memory, has not been previously addressed.
NALC neurons have divergent input/output architecture and are involved in various physiological functions such as stress response, attention, arousal, cognitive function, and reward-seeking behavior9,10,11. In addition, NA transmission is involved in anxiety and phobia12. In the rodent LA, noradrenaline is known to be a critical modulator of fear memory formation via-adrenergic receptor activation (βARs)13,14, while in humans, β-AR blockers disrupt fear memory consolidation15.
While it had been suggested that the lateral hypothalamus (LH), where orexin neurons are localized, is not involved in Pavlovian fear learning16, recent data demonstrate that orexin neuron plays an important role in fear memory learning and consolidation8,17, as well as fear memory extinction18. From these findings, we hypothesized that orexin neurons, which respond to emotional stimuli, can also modulate the expression of fear via noradrenergic signaling governed by NALC→LA neurons.
Here, we employed the cell-type-specific tracing of the relationship between input and output (cTRIO) approach19, to histologically identify monosynaptic connections between orexin neurons and NALC→LA neurons, and used chemogenetic or optogenetic manipulations of these circuits. Enhancement of orexinergic activity by these manipulations as well as fasting increased fear-related behavioral responses through the OX1R signaling in the LC. This study demonstrates that the pathway constituting orexinLH→LC and NALC→LA neurons positively regulate and physiologically modulates the level of fear-induced behavior in response to environmental information.
Role of OX1R in NALC neurons in fear expression
Mice with a global deletion of the OX1R demonstrated decreased freezing in both cued and contextual fear tests, and rescue of OX1R only in NALC neurons completely normalized the phenotype8. Here, using mice lacking the OX1R receptor specifically in NALC neurons (OX1 Rf/f ; NAT-Cre mice) (Supplementary Fig. 2), we confirmed the role of OX1R in NALC neurons in cued fear conditioning test (Fig. 1a, b). While both genotypes showed similar freezing levels during training (OX1R f/f, n = 8; OX1R f/f; NAT-Cre, n = 12: two-way RM ANOVA with Sidak’s post-hoc test, F (1, 18) = 2.673, p = 0.1194, Fig. 1c), OX1R f/f; NAT-Cre mice showed a significant deficit in freezing in test session (freezing over time: two-way RM ANOVA with Sidak’s post-hoc test, F (1, 18) = 7.177, p = 0.0153, Fig. 1d, left; average freezing: unpaired two-tailed Student’s t test, t = 2.994, p = 0.0085, Fig. 1d, right). NAT-Cre mice with normal OX1R alleles did not show any abnormality in the cued- and contextual fear test as compared with wild-type littermates, suggesting that existence of NAT-Cre allele did not affect the phenotype (Supplementary Fig. 2f–h). This phenotype of OX1R f/f; NAT-Cre was highly similar to the findings in OX1R −/− mice in our previous work8 and suggests that OX1R in NALC neurons plays a major role in fear memory consolidation and/or expression. To examine whether the function of OX1R is necessary particularly during the fear memory retrieval period, we next used acute pharmacological blockade with a selective OX1R antagonist (SB334867) (Fig. 1e). One day after fear conditioning, in which freezing was comparable between genotypes (vehicle, n = 13; SB334867, n = 13, two-way RM with Sidak’s post-hoc test, F (1, 24) = 1.086, p = 0.3077, Fig. 1f), mice receiving an intraperitoneal (i.p.) injection of SB334867 (5 mg/kg)18 1 h before the test session. The effect of the antagonist was not evident for first 30 s of CS presentation, but we observed reduction in freezing behavior for later period (freezing over time: two-way RM ANOVA with Sidak’s post-hoc test, F (1, 24) = 11.47, p = 0.0024, 3.5–5 min in Fig. 1g, left; average freezing: unpaired two-tailed Student’s t test, t = 4.411, p = 0.0002, Fig. 1g, right). These results demonstrate that OX1R activates the NALC neurons to maintain behavioral fear expression.
Inhibition of NALC neurons reduced cue-induced freezing response
OX1R f/f; NAT-Cre mice showed decreased freezing during the retrieval period (Fig. 1d) and pharmacological blockade of OX1R impairs sustained expression of freezing behavior against CS (Fig. 1g), suggesting that OX1R in NALC neurons modulates and maintains fear expression in response to the external fearful stimuli. To further evaluate this hypothesis, we perfomed chemogenetic inhibition of NALC neurons during the cued test session. We bilaterally injected AAV 10 -EF1α-FLEX (loxP)-hM4Di-mCherry (hM4Di) in the LC of NAT-Cre mice to express hM4Di specifically in NALC neurons (Fig. 2a). Two weeks after injection, we performed cued fear conditioning, in which we did not observed any difference in freezing between the groups (NAT-Cre+;hM4Di (Saline), n = 7; NAT-Cre+;hM4Di (CNO), n = 6: two-way RM ANOVA with Sidak’s post-hoc test, F (1, 11) = 0.2306, p = 0.6405, Fig. 2b). One day later, we subjected these mice to a test session 40 min after i.p. injection of CNO to inhibit NALC neurons. The CNO-treated group showed gradually reduced freezing, with the difference most obvious in the later phase of CS presentation (freezing over time: two-way RM ANOVA with Sidak’s post-hoc test, F (1, 11) = 5.145, p = 0.1526, Fig. 2c, left; average freezing: unpaired two-tailed Student’s t test, t = 3.573, p = 0.0044, Fig. 2c, right). After testing, we confirmed specific expression of hM4Di in NALC neurons (Fig. 2d), and quantified c-Fos expression in TH-labeled cells and Fos- and mCherry-labeled cells in the LC, finding a significant reduction following CNO injection (NAT-Cre+;hM4Di (Saline), n = 3; NAT-Cre+;hM4Di (CNO): unpaired two-tailed Student’s t test, n = 3: t = 9.309, p = 0.0024, Fig. 2e, f) (NAT-Cre+;hM4Di (Saline), n = 4; NAT-Cre+;hM4Di (CNO): unpaired two-tailed Student’s t test, n = 4: t = 3.404, p = 0.0283, Fig. 2g). To exclude the possibility that CNO itself affects freezing behavior, we tested the effect of i.p. injection of CNO in wild-type mice. After cued fear conditioning (saline, n = 5; CNO, n = 5: two-way RM ANOVA, F (1, 8) = 0.03348, p = 0.8594, Fig. 2h), fear response did not change between saline- and CNO injected group against cued (two-way RM ANOVA with Sidak’s post-hoc test, F (1, 8) = 0.0003, p = 0.9847) and contextual stimuli (two-way RM ANOVA with Sidak’s post-hoc test, F (1, 8) = 0.00145, p = 0.9706) (Fig. 2i, j, left). Average freezing showed no difference among these groups during CS presentation (unpaired two-tailed Student’s t test, t = 0.3564, p = 0.7314) or exposure to the context A (unpaired two-tailed Student’s t test, t = 0.03794, p = 0.9706) (Fig. 2i, j, right).
Orexin neurons make direct synaptic input to NALC→LA neurons
Although it has been well established that NALC neurons receive dense projection from orexin neurons20, and these neurons innervate the LA to modulate amygdala function14, confirmation of the direct connections between these components has not been achieved. Using the cTRIO method19, we examined whether orexin neurons make monosynaptic connections to NALC→LA neurons. We injected a Cre-dependent CAV2 vector carrying the flippase (Flp) recombinase (CAV2-FLEX (loxP)-Flp) into the LA of NAT-Cre mice21. Because CAV2 infects axons and is retrogradely transported to cell bodies, this combination allows us to express Flp specifically in Cre-expressing NALC→LA neurons. We then injected the Flp-activatable AAV vectors, AAV 10 -CAG-FLEX (Frt)-TVA-mCherry and AAV 10 -CAG-FLEX (Frt)-RG, into the LC to express TVA and rabies glycoprotein (RG) in these cells. Finally, we injected SADΔG-EGFP (EnvA) 22 in the same regions (LC) to label upstream neurons that make direct synaptic contact with NALC→LA neurons. We confirmed that NALC (TH-positive) neurons express TVA and SADΔG-EGFP, demonstrating that a population of NALC neurons send axonal projections to the LA (Fig. 3a, b). As expected, we found that some orexin neurons is the LH express SADΔG-EGFP, indicating that orexin neurons have monosynaptic connectivity to NALC neurons (Fig. 3c) and suggesting that orexin neurons directly regulate NALC→LA neurons. In all experiments (n = 4), TH, TVA, SADΔG-EGFP co-labeled neurons were restricted to the caudal region of the LC (Fig. 3d), suggesting that the LA receives input mainly from neurons in the posterior part of the LC. The fraction of starter cells represented 16.11 ± 0.96% of all NALC neurons (Fig. 3e). We also found input cells in regions other than the LH, including the paraventricular nucleus of the hypothalamus (PVN) and the central nucleus of the amygdala (CeA) and medial parabrachial nucleus (MPB), suggesting that NALC→LA neurons receive input from these regions in addition to orexin neurons (Supplementary Fig. 3).
Inhibition of the orexinLH→LC pathway reduces cued fear expression
To evaluate the function of the pathway identified by the cTRIO (Fig. 3), we examined whether optogenetic silencing of the orexinLH→LC pathway during CS presentation affects freezing behavior. We bilaterally injected AAV 10 -EF1α-FLEX (loxP)-vLWO-EGFP (vLWO, inhibitory Gi/o coupling vertebral cone opsin)23 into the LH of Orexin-Cre mice, in which orexin neurons specifically express Cre recombinase24. We unilaterally implanted an optic fiber in the LC to test the effect of optogenetic inhibition of these axon terminals during cued fear test (Fig. 4a, b, g). We confirmed the expression of vLWO (75.24 ± 5.58% orexin neurons expressed vLWO) and the position of optic fiber after each experiment, and only used the data when vLWO was specifically expressed in orexin neurons and optic fibers were adjacent to the LC (Fig. 4c). Following conditioning (Orexin-Cre-;vLWO, n = 4; Orexin-Cre+;vLWO, n = 6: two-way RM ANOVA with Sidak’s post-hoc test, F (1, 8) = 0.3154, p = 0.5898, Fig. 4d), optogenetic inhibition of orexinergic fibers in the LC during CS representation attenuated freezing, with the effect again more evident in the later phase of CS presentation (freezing over time: two-way RM ANOVA with Sidak’s post-hoc test, F (1, 8) = 12.68, p = 0.0074, Fig. 4e, left; average freezing: unpaired two-tailed Student’s t test, t = 4.400, p = 0.0023, Fig. 4e, right). Auditory CS or laser stimulation without prior conditioning had no effect on freezing behavior (one-way ANOVA, F (7, 32) = 1.049, p = 0.4179, Fig. 4f). Furthermore, optogenetic silencing had no effect when the optic fibers were not correctly implanted above the LC (Supplementary Fig. 4). Fos induction in NALC neurons by the CS was significantly decreased with the optogenetic inhibition (Orexin-Cre-;vLWO, n = 3; Orexin-Cre+;vLWO, n = 5: unpaired two-tailed Student’s t test, t = 4.919, p = 0.0218, Fig. 4h, i). Because orexin neurons are physiologically activated by fear-related cues (Supplementary Fig. 1), they are likely to lead to excitation of NALC neurons. Our results suggest that inhibitory manipulation of this excitation impairs behavioral expression of fear.
Upregulation of orexin signaling in the LC augments freezing
Given that the orexin neurons are activated during behavioral fear expression (Supplementary Fig. 1), and orexinLH→LC pathway plays a role in enhancing and sustaining freezing behavior, it might be also possible to induce or modulate fear-related behavior by artificially stimulating this circuit. To test this hypothesis, we injected AAV 10 -EF1α-FLEX (loxP)-ChR2-EYFP (ChR2) into the LH of Orexin-Cre mice to express ChR2 specifically in orexin neurons (74.49 ± 5.35% orexin cells expressed ChR2), and unilaterally implanted an optic fiber at the LC to activate axonal terminals of orexin neurons (Fig. 5a, b). We confirmed the expression of ChR2 after each experiment. We observed selective expression of ChR2 in orexin neurons as well as many ChR2-EYFP-positive fibers in the LC (Fig. 5c). Twenty-four hours after conditioning in “context A” in which both groups showed similar freezing level (Orexin-Cre-;ChR2, n = 7; Orexin-Cre+;ChR2, n = 5: two-way RM ANOVA with Sidak’s post-hoc test, F (1, 10) = 0.0026, p = 0.9600, Fig. 5d), we put these mice into a similar but distinct context (context A′), and optogenetically excited orexin fibers in the LC in the absence of the auditory CS. Context A′ normally did not evoke freezing behavior as shown in first 150-s of Fig. 5e. However, following the 150-s baseline phase, 150-s laser stimulation of orexin fibers in the LC evoked robust freezing behavior (freezing over time: two-way RM ANOVA with Sidak’s post-hoc test, F (1, 10) = 23.38, p = 0.0007, Fig. 5e, left, Movie Fig. 1; average freezing: unpaired two-tailed Student’s t test, t = 5.450, p = 0.0010, Fig. 5e, right).
Freezing was not evoked in mice without prior conditioning (Orexin-Cre-;ChR2 (not conditioned), n = 7; Orexin-Cre+;ChR2 (not conditioned), n = 5: one-way ANOVA with Tukey’s post-hoc test, F (7, 40) = 0.9152, p = 0.5049, Fig. 5f). To assess the effectiveness of optogenetic stimulation, we confirmed an increase of Fos+/TH+ cells in NALC neurons (WT (control), n = 4; WT (CS+), n = 3; Orexin-Cre-;ChR2, n = 3; Orexin-Cre+;ChR2, n = 3: one-way ANOVA with Tukey’s post-hoc test, F (3, 9) = 14.82, p = 0.0008, Fig. 5g, h). In addition, optogenetic stimulation did not affect behavior unless the optic fibers were precisely implanted above the LC region (Supplementary Fig. 5). Finally, we examined whether freezing responses induced by the orexinLH→LC stimulation require OX1R signaling. Twenty-four hours after fear conditioning (Orexin-Cre+;ChR2 (vehicle), n = 4; Orexin-Cre+;ChR2 (SB334867), n = 5: two-way RM ANOVA with Sidak’s post-hoc test, F (1, 7) = 0.1756, p = 0.6877, Fig. 5i), SB334867 or vehicle was administered i.p. to Orexin-Cre mice expressing ChR2 in orexin neurons. One hour after drug administration, we optogenetically stimulated orexin fibers in the LC. The photostimulation-induced freezing response was abolished in the SB334867-treated group (freezing over time: two-way RM ANOVA with Sidak’s post-hoc test, F (1, 7) = 20.61, p = 0.0027, Fig. 5j, left; average freezing: unpaired two-tailed Student’s t test, t = 3.972, p = 0.0144, Fig. 5j, right), suggesting this response is mediated through OX1R. Also, photostimulation itself did not induce any behavioral change without prior cued fear conditioning (Orexin-Cre-;ChR2 (not conditioned), n = 4; Orexin-Cre+;ChR2 (not conditioned), n = 5: one-way ANOVA with Tukey’s post-hoc test, F (7, 28) = 0.7448, p = 0.6366, Fig. 5k), showing that activation of the orexinLH→LC signaling evokes fear expression only when the aversive US is already paired with a similar, but distinct context.
Stimulation of NA signaling in the LA enhances freezing
Because activation of orexin fibers in the LC evoked an enhanced fear response in a distinct but similar context (Fig. 5), and orexin neurons make monosynaptic contacts on NALC→LA neurons (Fig. 3), NALC→LA neurons might play an important role as a downstream effector in orexin neurons-evoked fear generalization. Thus, we next tested whether excitation of NA fibers in the LA also affect fear-related responses (Fig. 6a). We selectively restricted ChR2 expression in NALC neurons by bilateral injection of AAV 10 -EF1α-FLEX (loxP)-ChR2-EYFP into the LC of NAT-Cre mice (Fig. 6b) and unilaterally implanted an optical fiber in the LA. We confirmed focal expression of Cre-dependent ChR2 in NALC neurons (83.40 ± 3.18%) and fibers in the LA (Fig. 6c). Twenty-four hours after fear conditioning in context A (NAT-Cre-;ChR2, n = 7; NAT-Cre+;ChR2, n = 6: two-way RM ANOVA with Sidak’s post-hoc test, F (1, 11) = 0.9080, p = 0.3611, Fig. 6d), we illuminated NA fibers in the LA in an altered context (A′) without applying the auditory CS. After a 150-s rest phase, 150-s laser stimulation of NA fibers in the LA markedly increased freezing (freezing over time: two-way RM ANOVA with Sidak’s post-hoc test, F (1, 11) = 14.30, p = 0.0030, Fig. 6e, left, Movie Figs. 2 and 3; average freezing: unpaired two-tailed Student’s t test, t = 5.279, p = 0.0004, Fig. 6e, right). Although we did not monitor firing rate of NALC neurons in fearful condition, Takeuchi et al reported that these neurons showed burst firing at ranging from 15.3 to 28.2 Hz when the mice were put into the novel cage, although basal firing rate is 0.23–6.03 Hz25. Based on this observation, we here used pulses of 473 nm illumination at 20 Hz (pulse width = 35 ms, interval = 15 ms, 10 mW) for the photostimulation. Again, we did not see a photostimulation-induced freezing response in context A′ without prior fear conditioning in context A (NAT-Cre-;ChR2 (not conditioned), n = 6; NAT-Cre+;ChR2 (not conditioned), n = 6: one-way ANOVA with Tukey’s post-hoc test, F (7, 40) = 0.7440, p = 0.6364, Fig. 6f). After optical stimulation, we validated Fos-positive cells in the LA. Fos-positive cells were increased by optogenetic manipulation (WT (control), n = 4; WT (CS+), n = 3; NAT-Cre-;ChR2, n = 3; NAT-Cre+;ChR2, n = 4: one-way ANOVA with Sidak’s post-hoc test, F (3, 10) = 10.66, p = 0.0019, Fig. 6g, h), suggesting that the noradrenergic influence on LA neurons is excitatory. When optic fibers were not precisely implanted at the LA, photostimulation did not evoke any effect in the conditioning and test sessions (Supplementary Fig. 6).
The maximum freezing time observed with optogenetic activation was comparable to the CS-evoked freezing time in WT mice (Supplementary Fig. 7a), although the responses were usually delayed as compared with those induced by auditory cues (Supplementary Fig. 7b), presumably due to the slow neurotransmission governed by the peptidergic and monoaminergic systems. These observations suggest that with the optogenetic stimulation of orexin fibers in the LC or NA fibers in the LA, mice responded to trace elements of the contexts, which normally are not recognized by mice as danger, facilitating the expression of learned fear responses against circumstances that differ from those during acquisition of the fear memory26. This is akin to the response observed in PTSD patients, raising the possibility that over-activation of NALC neuorns could underlie the pathological behavioral response, such as fear generalization, seen in PTSD or panic disorder.
Physiological increase of orexinergic tone modulates freezing
Our various manipulations of the circuits involving orexinLH→LC and NALC→LA neurons established that this pathway is important for the proper expression of freezing behavior. However, it is not clear whether a physiological activation of this neural circuit could actually influence animals’ behavior in a real-world situation. To explore the effects of physiological activation of orexin neurons on fear-related behavior, we used fasting, a manipulation which is well known to activate orexin neurons27,28,29,30. Six hour after cued fear conditioning in the context A, mice were deprived of food for 16 h and then subjected to a test in context A′ in the absence of the CS (Fig. 7a). Fasting significantly changed the mouse’s body weight (Fed + Veh, n = 8; Fasted + Veh, n = 7; Fasted + SB, n = 8: one-way ANOVA with Tukey’s post-hoc test, F (2, 20) = 129.1, p < 0.0001, Fig. 7b). We implanted stainless cannulae bilaterally above the LC for acute SB334867 injection (Fig. 7c). After cued fear conditioning (two-way RM ANOVA with Tukey’s post-hoc test, F (2, 20) = 0.02, p = 0.9802, Fig. 7d) and fasting, mice showed increased freezing response even in a distinct but similar context (context A′). We also found that the fasting-induced freezing was attenuated with an OX1R antagonist, SB334867 focally injected in the LC (freezing over time: two-way RM ANOVA with Tukey’s post-hoc test, F (2, 20) = 7.850, p = 0.0030, Fig. 7e, left; average freezing: one-way ANOVA with Tukey’s post-hoc test, F (2, 20) = 7.852, p = 0.0030, Fig. 7e, right), suggesting that OX1R in the LC is involved in enhanced fear expression induced by fasting. The negative correlation between weight change and freezing response disappeared in fasted mice when administered SB334867 in the LC (n = 15, r = −0.5636, p < 0.05; n = 16, r = 0.2120, p = 0.4306, Fig. 7f, g). Neuronal activity evaluated with Fos in each component of the circuit was elevated following fasting, suggesting this circuit is engaged during freezing in context A′. The activation of NALC neurons and LA neurons by fasting were inhibited with administration of SB3348687 in the LC without any change in the activity of orexin neurons, suggesting that orexinLH→LC to NALC→LA circuit is mobilized by freezing (orexin; Fed + Veh, n = 3; Fasted + Veh, n = 5; Fasted + SB, n = 6: one-way ANOVA with Sidak’s post-hoc test, F (2, 11) = 10.69, p = 0.0026; NALC; Fed + Veh, n = 4; Fasted + Veh, n = 3; Fasted + SB, n = 4: one-way ANOVA with Tukey’s post-hoc test, F (2, 8) = 9.596, p = 0.0075; LA; Fed + Veh n = 4; Fasted + Veh, n = 4; Fasted + SB, n = 4: one-way ANOVA with Tukey’s post-hoc test, F (2, 9) = 19.61, p = 0.0005, Fig. 7h). Similar result was obtained in the experiment with i.p. injection of SB334867 (Supplementary Fig. 8).
Activation of orexin signaling in the LC augments cued fear response
Optogenetic stimulation of orexinLH→LC or NALC→LA pathways resulted in a robust increase of freezing in context A′ without CS (Figs. 5 and 6). We postulated that this freezing was evoked by similar contextual elements between context A′ and context A. We further examined whether explicit cues that are normally are not recognized as danger, but contains similar elements also induce freezing when paired with excitation of the orexinLH→LC pathway. To achieve this, we presented mice with two different auditory CSs, one never paired with shock and one always paired with shock (CS1, white noise and CS2, tone) (Fig. 8a, b). We injected AAV 10 -EF1α-FLEX (loxP)-ChR2-EYFP or AAV 10 -EF1α-FLEX (loxP)-EYFP into the LH of Orexin-Cre mice to specifically express ChR2 or EYFP in orexin neurons. Prior to conditioning, neither CS1 nor CS2 triggered freezing behavior, even when paired with optogenetic simulation of the orexinLH→LC pathway (Orexin-Cre+;ChR2-EYFP, n = 5; Orexin-Cre+;ChR2, n = 5: one-way ANOVA with Tukey’s post-hoc test F (5, 24) = 1.260, p = 0.3131, F (5, 24) = 0.5857, p = 0.7107, Fig. 8c). We did not observe significant differences in freezing between ChR2-injected and EYFP-injected mice during training (two-way RM ANOVA with Sidak’s post-hoc test F (1, 8) = 0.5120, p = 0.4946, Fig. 8d) with both groups showing significantly more freezing to CS2 compared to CS1 (CS1, n = 10; CS2, n = 10: two-way RM ANOVA with Sidak’s post-hoc test F (1, 9) = 6.593, p = 0.0303 Fig. 8e). After conditioning, we performed testing with optogenetic manipulation in the homecage to exclude any influence by contextual elements. Notably, optogenetic activation of the orexinLH→LC pathway in the absence of any CS did not evoke freezing (freezing over time: two-way RM ANOVA with Sidak’s post-hoc test F (1, 8) = 0.2447, p = 0.6341, Fig. 8f, left; average freezing: one-way ANOVA with Tukey’s post-hoc test F (3, 16) = 2.949, p = 0.0643 Fig. 8f, right). CS1 presentation alone induced small increase in freezing in both groups. However, laser stimulation during CS1 application led to a large increase in freezing in mice expressing ChR2 in orexin neurons (two-way RM ANOVA with Sidak’s post-hoc test F (1, 8) = 9.648, p = 0.0145, Fig. 8g, left). A comparison of average freezing times revealed that ChR2-expressing mice compared to EYFP controls only showed elevated freezing when laser stimulation was applied during CS1 presentation (one-way ANOVA with Tukey’s post-hoc test F (7, 32) = 5.682, p = 0.0003, Fig. 8g, right). These results suggest that the orexinLH→LC pathway modulates the behavioral expression of fear against an auditory cue.
Our present study establishes that orexinLH→LC and NALC→LA neurons form a circuit, which plays a critical role in the regulation of freezing behavior. Our data integrate previous findings to provide a deeper understanding of the roles of orexin neurons in emotional responses and suggest that these neurons not only increase the sympathetic nervous outflow31 and arousal, but also play a crucial role in ensuring the expression of an appropriate behavioral response. We demonstrated that orexin neurons are strongly activated by fearful situations32 (Supplementary Fig. 1), which is likely to lead to activation of downstream pathways, including NALC→LA neurons. Genetic or pharmacological blockade of OX1R, a receptor abundantly expressed in NALC neurons, resulted in a significant reduction of CS-mediated freezing. Although we could not compare result from two separated experiments, the effect of the antagonist seems to be larger as compared with local deletion of OX1R in NALC neurons (Fig. 1g), suggesting that another pathway (s) involving OX1R signaling might play an additional role.
A previous study reported that acute blockade of OX1R did not affect fear memory retrieval during random presentations of a 30-s CS17. Our results are consistent with this, as neither inhibitory antagonist administration, nor inhibitory manipulations with pharmacogenetics and optogenetics affected freezing time during the initial 30-s of CS presentation. Rather, these manipulations resulted in a reduction of freezing response in the later phase of CS presentation (Figs. 1, 2, and 4), suggesting the function of orexin system in sustaining the behavioral expression of fear rather than the expression of fear-related behavior itself. Furthermore, the function of orexin in the regulation of fear-related behavior is consistent with the previous observation that human narcolepsy patients, who lack orexin signaling, have an impaired fear response and show reduced amygdala activity when exposed to aversive conditioned stimuli33,34.
In this study, we confirmed that orexin neurons make direct synaptic contact with NALC→LA neurons (Fig. 3), suggesting the existence of orexinLH→LC to NALC→LA pathway. SADΔG is likely to be effectively transported from post-synaptic neurons to pre-synaptic neurons only when the synapses between these two neurons are tight. Although peptidergic neurons can form tight synapses, the majority are thought to be loose synapses, thus we speculate that the number of labeled orexin neurons in our cTRIO experiment (Fig. 3) might be an underestimate of the actual connectivity. Orexin neurons have broad projections to targets employing diverse post-synaptic receptors and signaling complexes, thus they are also well suited to mediate other various aspects of the fear responses, including freezing, cardiovascular function, and stress response in response to emotionally salient stimuli3,35,36. Among them, we found that circuit composed of orexinLH→LC and NALC→LA neurons plays an important role in regulation of fear-related behavior. Activation of this circuit increased freezing behavior even in a context distinct from the training context (Figs. 3 and 4). With the optogenetic activation, mice recognize elements common to both contexts as signal that is associated with dangerous outcomes. This signal might be normally attenuated by top–down inhibitory signals from regions such as the prefrontal cortex37, but becomes evident when the orexin system is mobilized. Alternatively, NA signaling in the LA might increase attention to trace elements that suggest danger. After fear conditioning in a given context (such as context A), mice tend to exhibit slightly increased freezing (less than 20%) in an altered but similar context (A′), suggesting that the animals recognize some elements of this context as cues that predict aversive outcome (Supplementary Fig. 9). Increased activation of the orexinLH→LCor NALC→LA circuits enhanced the fear response in context A′, revealing the ability of this circuit to open the “gate of fear.” In other words, the increase of the activity in these circuits might shift an anxiety state to one of actual fear. Consistent with this, optogenetic simulation of orexinLH→LC did not increase freezing in the homecage following fear conditioning (Fig. 8f). This supports the hypothesis that NALC→LA circuit gates fear against trace elements, which are normally ignored as indicators of danger and orexin regulates this activity. Furthermore, we observed similar results when we examined the impact of excitatory manipulation of orexinLH→LC circuit during the presentation of an auditory cue that was not explicitly predictive of the US (Fig. 8g).
The optogenetic manipulations on orexinLH→LC or NALC→LA circuits resulted in fear generalization, a process of emergence of fear against a stimulus or context to related cues or similar situations previously paired with aversive experiences. These observations raise the possibility that activation of orexin neurons may underlie the internal condition that evokes fear generalization. From another perspective, stressful conditions, such as fasting, could result in an orexin-dependent shift to a “vigilance” state and alter the selection of a behavioral response to avoid and handle environmental threats in real-world situation.
Our study also suggests that the inhibition of OX1R may provide a promising avenue for treating psychiatric conditions that are characterized by exaggerated and/or inappropriate fear-related responses and anxiety triggered by external cues, such as panic disorder and PTSD.
All experimental procedures involving mice were approved by the Animal Experiment and Use Committee of University or Kanazawa University (AP-111947) and Tsukuba University (16–397), and were thus in accordance with NIH guidelines. We used BAC-transgenic NAT-Cre mice21, and Orexin-Cre mice24 for Cre-dependent pharmacogenetic and optogenetic manipulation. We confirmed highly specific expression of Cre recombinase in NALC neurons by mating NAT-Cre mice with Rosa26Sor tm1sor reporter mice and did not detect any ectopic expression in other regions (Supplementary Fig. 2b). We generated OX1R f/f ;NAT-Cre mice (Supplementary Fig. 2), in which OX1R is selectively deleted in NALC neurons, for cued fear conditioning experiments. Mice were maintained under a strict 12-h light–dark cycle in a temperature- and humidity-controlled room and fed ad libitum.
We used recombinant AAV vectors with the FLEX switch38 system to specifically express ChR2 or vLWO, hM4Di (DREADD) in Cre-expressing neurons. We used long-wavelength vertebral cone opsin (vLWO) for optogenetic inhibition. vLWO activates the Gi/o pathway in neurons to activate Kir3 channels23. Human red opsin (vLWO) cDNA clone was excised from a plasmid pAAV-CMV-FLEX (loxP)-vLWO. The excised vLWO was cloned into pAAV-EF1α-FLEX (loxP)-hChR2 (H134R)-EYFP-WPRE-pA. We used pAAV-EF1α-FLEX (loxP)-hM4Di(Gi)-mCherry (provided by Dr Bryan Roth), pAAV-EF1α-FLEX (loxP)-hChR2(H134R)-EYFP-WPRE-HGHpA (provided by Dr Karl Deisseroth), pAAV-EF1α-FLEX (loxP)-EYFP-WPRE-HGHpA (Addgene plasmid # 20296). pAAV-CAG-FLEX (Frt)-TVA-mCherry and pAAV-CAG-FLEX (Frt)-RG (rabies glycoprotein) were provided by Dr Miyamichi (Tokyo University). All viral plasmids were packed with pHelper (Stratagene) and pAAV2-rh10 (provided by Penn Vector Core) with a triple transfection, helper-free method39. We also purchased CAV2-FLEX (loxP)-Flp virus from Biocampus Montpellier. pcDNA-SADB19L (#32632), pcDNA-SADB19G (#32633), pcDNA-SADB19N (#32630), pcDNA-SADB19P (#32631), and pSADdeltaG-GFP-F2 (#32635) were obtained from Addgene. We made SADdΔG-GFP(EnvA) by transfecting these plasmids in B7GG cells, followed by pseudotyping in BHK-RGCD-EnvA cells, and ultracentrifugation40. The titers of virus vectors were: AAV 10 -EF1α-FLEX (loxP)-ChR2-EYFP; 3.7 × 1013, AAV 10 -EF1α-FLEX (loxP)-hM4Di-mCherry; 1.90 × 1012, AAV 10 -EF1α-FLEX (loxP)-vLWO- EGFP; 7.04 × 1012, AAV 10 -EF1α-FLEX (loxP)-EYFP; 5.82 × 1013 (genomic copies/ml), CAV2-FLEX (loxP)-Flp (purchased from Biocampus Montpellier), AAV 10 -CAG-FLEX (Frt)-TVA-mCherry; 4 × 1013 , AAV 10 -CAG-FLEX (Frt)-RG; 3.9 × 1013 (genome copies/ml), and SADΔG-EGFP (EnvA); 4.2 × 108 infectious units/ml.
The orexin receptor-1 antagonist, SB334867 (Tocris) (5 mg/kg), was dissolved in 1% dimethyl sulfoxide in distilled water. SB334867 and vehicle were injected i.p. 1 h before the cued fear test session of fear conditioning (Fig. 1e–g). Same drug and procedure was used for optogenetic experiment to activate orexinLH→LC neurons (Fig. 5i–k), and other experiment with combination of fasting and fear conditioning (Supplementary Fig. 8). For microinjection experiment, we used SB334867 in physiological saline (10 nmol/0.5 µl) or saline (Veh) 30 min before test session (Fig. 7). All these doses were based on previous study18 . For hM4Di (DREADD) experiments, clozapine-N-oxide (CNO) (5 mg/kg) or saline was injected i.p. 40 min before the test session (Fig. 2a).
For the inhibitory DREADD experiment, NAT-Cre mice (12 weeks old) were anesthetized with sodium pentobarbital (0.5 mg/kg, i.p.) and positioned in a stereotaxic frame (David Kopf Instruments). AAV 10 -EF1α-FLEX (loxP)-hM4Di-mCherry was injected into the LC (AP, −5.4 mm; ML, ± 0.9 mm; DV, −3.65 mm; 0.6 µl in each site) over a 10-min period. For optogenetic manipulation of orexin neurons, Orexin-Cre mice were injected with AAV 10 -EF1α-FLEX (loxP)-vLWO-EGFP or AAV 10 -EF1α-FLEX (loxP)-ChR2-EYFP bilaterally into the LH (AP, −1.4 mm, −1.8 mm; ML, ±0.9 mm; DV, −5.5, −5.7; 0.25 µl in each site). Then, an optical fiber was implanted above the LC (AP, −5.4 mm; ML, +0.9 mm; DV, −3.3 mm). For optogenetic activation of NALC neurons, NAT-Cre mice were injected with AAV 10 -EF1α-FLEX (loxP)-ChR2-EYFP bilaterally into the LC (same sites as DREADD experiment; 0.8 µl in each site). Then, an optical fiber was implanted at the LA (AP, −1.8 mm; ML, +3.25 mm; DV, −3.75 mm). After a 14-day recovery period in individual cages after injection, mice were subjected to behavioral experiments, and then killed and brain samples were collected for immunohistochemical examination. Behavioral data were only included if these viruses were targeted specifically and the fiber optic implants were precisely placed. For microinjection of SB334867 directly into the LC, we bilaterally implanted stainless cannula just above the LC (AP, −5,4 mm; ML, ±0.9 mm; DV, −3.2).
All experiments were performed during the light phase (13:00–16:00) using male 12 to 14-week-old mice. Prior to the experiments, these mice were isolated for 2 weeks. The experimenters were blind to the genotypes until all data had been gathered and analyzed. We performed same cued fear conditioning paradigms with modified retrieval test using longer CS presentation (150 s) than the previous protocols8. We used this condition, because we found this robustly excited NALC neurons (Fig. 5). For the cued fear conditioning test, mice were placed in a conditioning chamber (Context A; 15 × 12 × 13 cm) for 90 s before giving a conditioned stimulus (CS), a 2900 Hz, 80 dB tone, which lasted 30 s, immediately followed by the presentation of an unconditioned stimulus (US), a mild foot shock of 0.3 mA for 2 s, on the training day. We also used 0.4 mA for 2 s in fasting experiment (Fig. 7 and Supplementary Fig. 8). Five consecutive sessions of training were performed. After an additional stay for 90 s in the chamber, the mouse was returned to its homecage. Test sessions were performed 24 h after the training. The test session was conducted in a chamber (Context A′; 13 × 20 × 30 cm) with a different context (a different cage surrounded by a monochrome striped screen), and freezing behavior was scored during the test session. A memory test was performed with a 150-s rest period following the presentation of 150 s auditory CS. For the optogenetic inhibition experiments with vLWO in orexinLH neurons, 3000 pulses of 473 nm illumination at 20 Hz (pulse width = 35 ms, interval = 15 ms, 10 mW) were presented during a 150-s period. In the optogenetic experiments with ChR2, light pulses with different strength (15 mW) were presented in the same manner for 150 s following a 150-s period without shining laser. Frequency of the stimulation was based on the previous study focusing on the firing rate of LC neurons (15.3–28.2 Hz) when the mice were put into the novel context25.
For experiment shown in Fig. 8, we conducted optogenetic stimulation of orexin neurons with two different types of CS. We presented 30 s CS1 (white noise, 70 dB) 30 s before giving a CS2 (2900 Hz, 80 dB), which lasted 30 s, that was immediately followed by an unconditioned stimulus (US, 0.3 mA). We repeated the sequence five times. Twenty-four hours after the fear conditioning, we performed 150 s optogenetic stimulation of orexinLH→LC as described above, after 150 s of REST period in a homecage for recording the baseline (Test 1). Additionally, we performed 300 s CS1 presentation following 150 s REST, and illuminated the same pathway for 150 s in the latter half of CS1, then, we also observed the freezing behavior for 150 s after these manipulations (Test 2).
Freezing behavior was recorded with a charge-coupled device (CCD) video camera and analyzed with an auto tracking system, compACT VAS ver 3.0x (Muromachi Kikai, Tokyo). Data are presented as mean ± SEM.
Mice were anesthetized with sodium pentobarbital and then fixed by intracardiac perfusion with 4% paraformaldehyde. Then, the brain was post-fixed for 24 h in the same fixative and cryoprotected by immersion in 30% sucrose for 2 days. Brain sections of 30 µm thickness were cut with a cryostat. Sections were washed and blocked with 0.1 M phosphate-buffered saline (PBS) containing 0.25% Triton X-100 plus 3% bovine serum albumin (BSA). Then, slices were incubated with the designated primary antibodies in PBS overnight at 4 °C. Antibodies used in this study were guinea pig antibody against orexin B antibody (1:500), rabbit polyclonal antibody against Fos (1:5000, Ab-5, Millipore), mouse polyclonal antibody against tyrosine hydroxylase (1:2000, F-11, Santa Cruz), rat antibody against green fluorescent protein (GFP) (1:1000, Nakarai), goat polyclonal antibody against mCherry (1:500, SICGEN), and rabbit anti-beta galactosidase (Cappel 55796). Then, slices were washed with PBS three times, followed by incubation with designated secondary antibodies in PBS for 2.5 h. Secondary antibodies used in this study were Alexa 594-conjugated donkey anti-rabbit IgG, Alexa 594-conjugated donkey anti-mouse IgG, Alexa 594-conjugated donkey anti-guinea pig IgG, Alexa 488-conjugated donkey anti-mouse IgG, Alexa 488-conjugated donkey anti-rabbit IgG, Alexa 488-conjugated donkey anti-rat IgG, Alexa 488-conjugated donkey anti-guinea pig IgG, and Alexa 647-conjugated donkey anti-mouse IgG (1:1000; Molecular Probes, Eugene, OR). Slices were washed three times in PBS, mounted on subbed slides, air dried, and coverslipped using FluorSave Reagent (Calbiochem). For DAPI staining, slides were covered with DAPI-containing mounting reagent (Vector Laboratories). All images were taken on Olympus FV10i confocal microscope. The number of Fos+/TH+ cells in NALC neurons were counted in every 30 µm coronal section throughout the LC. We also evaluated the activity of orexin neurons by counting Fos+/Orexin+ cells in the LH. Fos+ cells in the LA were counted (cells per area) in coronal sections from −1.7 to −2.06 from the bregma using ImageJ. Cells were counted on both sides of these brain regions.
In situ hybridization
We performed in situ hybridization to detect OX1R mRNA in NALC neurons to evaluate the deletion of OX1R mRNA expression in NALC neurons of OX1R f/f ; NAT-Cre mice. Following the protocol described in previous study41, we stained OX1R with in situ hybridization combined with TH immunohistochemistry. First, 30 µm floating brain sections were treated with 4% paraformaldehyde and 0.3% Triton-X. After rinsing with PBS, the sections were incubated in 1% NaBH4 containing PBS for 30 min followed by 0.75% glycine in PBS (15 min, two times) and treated with 4% PFA. After rinsing with PBS, the sections were treated 0.5% acetic anhydrate for 15 min. After rinsing with PBS, we incubated the sections in hybridization buffer at 60 °C for 1.5 h followed by incubation with digoxigen-conjugated anti-sense OX1R RNA probes for 16 h at 60 °C. Then, sections were washed in 2× standard citrate saline (SSC) with 50% formamide/0.1% N-lauroylsarcosine reagent at 50 °C (20 min, two times) and incubated with RNase A treatment. After rinsing with 2× SSC with 0.1% N-lauroylsarcosine, 0.2× SSC with 0.1% N-lauroylsarcosine, and Tris-buffer saline (TBS, pH 7.5), the sections were treated with TBS (pH 7.5) containing 1% blocking reagent for 1.5 h. Then, the sections were treated with alkaline phosphatase-conjugated anti-digoxigenin (1:2000, Roche) and TH (1:2000, F-11, Santa Cruz) antibodies O/N at 4 °C. After rinsing TBS (pH 7.5)/0.1% Tween 20 followed by incubation of TBS (pH 7.5)/1% blocking reagent, the sections were incubated with Alexa 488-conjugated donkey anti-mouse IgG (1:1000; Molecular Probes, Eugene, OR) for 1 h. After rinsing with TBS (pH 7.5)/0.1% Tween 20 followed by TBS (pH 8.0) with 50 mM Mg solution, the sections were treated with Fast Red solution enhanced by HNPP (HNPP Fluorescent Detection Set, Roche). The sections were then washed with TBS (pH 7.5) and mounted on slide glasses. Images were acquired with a Leica SP8 confocal microscope.
To identify the orexinLH→LC to NALC→LA circuit, we used the trans-synaptic tracing (cTRIO) with combination of Cre- and Flp-dependent virus expression for rabies virus (SADΔG-EGFP (EnvA)19. We used NAT-Cre mice for retrograde expression of Cre-dependent Flp in the LC region. Flp lead to expression of Flp-dependent TVA and RG, which were necessary for expression and trans-synaptic transfer of SADΔG-EGFP (EnvA) in upstream neurons. NAT-Cre mice were anesthetized with sodium pentobarbital (0.5 mg/kg, i.p.) and injected with 0.4 µl of CAV2-FLEX(loxP)-Flp into ipsi-lateral LA using coordinates described above. A 1: two mixture (0.6 µl) of AAV 10 -CAG-FLEX(Frt)-TVA-mCherry and AAV 10 -CAG-FLEX (Frt)-RG into the left LC. Two weeks later, 0.6 µl of SADΔG-EGFP (EnvA) was injected into the LC using the procedure described above. Mice were kept in homecage for 5 days before killing. This manipulation labels NALC→LA cells (starter cells), and visualizes the upstream neuronal populations that make direct synaptic input to starter cells. We detected DAPI+/Orexin+/GFP+ cells in the LH and starter cells with DAPI+/mCherry+/TH+ cells in the LC. All images were taken on Olympus FV10i confocal microscope.
Six hours after cued fear conditioning, mice were fasted for 16 h before the test session in context A′. During fasting, food was removed but water was available ad libitum. Control mice could access to food and water ad libitum. Weight change of mice was measured before and after fasting procedure.
All data were expressed as mean ± SEM. We used one-way or two-way analysis of variance (ANOVA) followed by Sidak’s or Tukey’s post-hoc tests for serial freezing responses. Fos-positive cell count, or Student’s t test for average freezing responses and Fos-positive cell count. Pearson correlation coefficient was used for analyzing the strength of relationship between freezing vs. weight change, Orexin+/Fos+ cells vs. weight change, freezing vs. Orexin+/Fos+ cells. All statistics were performed using Graph Pad Prism 6.0b. Differences were considered significant at *p < 0.05, **p < 0.01, ***p < 0.001.
The authors declare that all data supporting the findings of this study are available within the article and its supplementary information file.
Fendt, M. & Fanselow, M. S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci. Biobehav. Rev. 23, 743–760 (1999).
LeDoux, J. E. Emotion circuits in the brain. Annu. Rev. Neurosci. 23, 155–184 (2000).
Sakurai, T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat. Rev. Neurosci. 8, 171–181 (2007).
Sakurai, T. The role of orexin in motivated behaviours. Nat. Rev. Neurosci. 15, 719–731 (2014).
Kayaba, Y. et al. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, 581–593 (2003).
Sakurai, T. et al. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 46, 297–308 (2005).
Yoshida, K., McCormack, S., Espana, R. A., Crocker, A. & Scammell, T. E. Afferents to the orexin neurons of the rat brain. J. Comp. Neurol. 494, 845–861 (2006).
Soya, S. et al. Orexin receptor-1 in the locus coeruleus plays an important role in cue-dependent fear memory consolidation. J. Neurosci. 33, 14549–14557 (2013).
Sara, S. J. Learning by neurones: role of attention, reinforcement and behaviour. C. R. Acad. Sci. III 321, 193–198 (1998).
Olson, V. G. et al. Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward. Science 311, 1017–1020 (2006).
Bouret, S. & Richmond, B. J. Relation of locus coeruleus neurons in monkeys to Pavlovian and operant behaviors. J. Neurophysiol. 101, 898–911 (2009).
Sullivan, G. M., Coplan, J. D., Kent, J. M. & Gorman, J. M. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Biol. Psychiatry 46, 1205–1218 (1999).
Bush, D. E., Caparosa, E. M., Gekker, A. & Ledoux, J. Beta-adrenergic receptors in the lateral nucleus of the amygdala contribute to the acquisition but not the consolidation of auditory fear conditioning. Front. Behav. Neurosci. 4, 154 (2010).
Johansen, J. P. et al. Hebbian and neuromodulatory mechanisms interact to trigger associative memory formation. Proc. Natl Acad. Sci. USA. 111, E5584–E5592 (2014).
Kindt, M., Soeter, M. & Sevenster, D. Disrupting reconsolidation of fear memory in humans by a noradrenergic β-blocker. J. Vis. Exp. 94, 1–8 (2014).
LeDoux, J. E., Iwata, J., Cicchetti, P. & Reis, D. J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J. Neurosci. 8, 2517–2529 (1988).
Sears, R. M. et al. Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus. Proc. Natl Acad. Sci. USA 110, 20260–20265 (2013).
Flores, A. et al. The hypocretin/orexin system mediates the extinction of fear memories. Neuropsychopharmacology 39, 2732–2741 (2014).
Schwarz, L. A. et al. Viral-genetic tracing of the input–output organization of a central noradrenaline circuit. Nature 524, 88–92 (2015).
Nambu, T. et al. Distribution of orexin neurons in the adult rat brain. Brain Res. 827, 243–260 (1999).
Gong, S. et al. Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs. J. Neurosci. 27, 9817–9823 (2007).
Wickersham, I. R., Finke, S., Conzelmann, K.-K. & Callaway, E. M. Retrograde neuronal tracing with a deletion-mutant rabies virus. Nat. Methods 4, 47–49 (2007).
Masseck, O. A. et al. Vertebrate cone opsins enable sustained and highly sensitive rapid control of Gi/o signaling in anxiety circuitry. Neuron 81, 1263–1273 (2014).
Matsuki, T. et al. Selective loss of GABA(B) receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture. Proc. Natl Acad. Sci. USA 106, 4459–4464 (2009).
Takeuchi, T. et al. Locus coeruleus and dopaminergic consolidation of everyday memory. Nature 537, 357–362 (2016).
Tryon, W. W. A neural network explanation of posttraumatic stress disorder. J. Anxiety Disord. 12, 373–385 (1998).
Sakurai, T. & Mieda, M. Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal. Trends Pharmacol. Sci. 32, 451–462 (2011).
Yamanaka, A. et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 38, 701–713 (2003).
Cai, X. J. et al. Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels. Diabetes 50, 105–112 (2001).
Diano, S., Horvath, B., Urbanski, H. F., Sotonyi, P. & Horvath, T. L. Fasting activates the nonhuman primate hypocretin (orexin) system and its postsynaptic targets. Endocrinology 144, 3774–3778 (2003).
Hilton, S. The defence-arousal system and its relevance for circulatory and respiratory control. J. Exp. Biol. 100, 159–174 (1982).
Furlong, T. M., Richardson, R. & McNally, G. P. Habituation and extinction of fear recruit overlapping forebrain structures. Neurobiol. Learn. Mem. 128, 7–16 (2016).
Khatami, R., Birkmann, S. & Bassetti, C. L. Amygdala dysfunction in narcolepsy-cataplexy. J. Sleep Res. 16, 226–229 (2007).
Ponz, A. et al. Reduced amygdala activity during aversive conditioning in human narcolepsy. Ann. Neurol. 67, 394–398 (2010).
Zhang, W., Zhang, N., Sakurai, T. & Kuwaki, T. Orexin neurons in the hypothalamus mediate cardiorespiratory responses induced by disinhibition of the amygdala and bed nucleus of the stria terminalis. Brain Res. 1262, 25–37 (2009).
Zhang, W. et al. Orexin neurons are indispensable for stress-induced thermogenesis in mice. J. Physiol. 588, 4117–4129 (2010).
Quirk, G. J. & Mueller, D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33, 56–72 (2008).
Atasoy, D., Aponte, Y., Su, H. H. & Sternson, S. M. A FLEX switch targets Channelrhodopsin-2 to multiple cell types for imaging and long-range circuit mapping. J. Neurosci. 28, 7025–7030 (2008).
Sasaki, K. et al. Pharmacogenetic modulation of orexin neurons alters sleep/wakefulness states in mice. PLoS ONE 6, e20360 (2011).
Osakada, F. & Callaway, E. M. Design and generation of recombinant rabies virus vectors. Nat. Protoc. 8, 1583–1601 (2013).
Mieda, M. et al. Differential roles of orexin receptor-1 and −2 in the regulation of non-REM and REM sleep. J. Neurosci. 31, 6518–6526 (2011).
The authors thank Drs K. Miyamichi, N. Uchida, and H. Osakada for providing the cells and plasmids for viral tracing and valuable discussion, Mr Arthur J.Y. Huang and the RIKEN BSI RRC for NAT-Cre mouse generation and Dr Maya Yamazaki and Ms Rie Natsume for OX1R f/f mouse generation. This study was supported by a Grant-in-Aid for JSPS Fellows (S.S), a KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas, “Adaptive circuit shift” (JP15H01425) (T.S.), Scientific Research (B) (JP 15H03122) (T.S.), Exploratory Research (T.S.) (JP 15K12768), CREST, JST, “Opto-Bio” (T.S.), SENSHIN Medical Research Foundation (T.S.), the Merck Investigator Studies Program (#54843) (T.S.), Novartis Foundation (T.M.), RIKEN BSI (T.J.M.), Deutsche Forschungsgemeinschaft Grants He2471/21-1, He2471/18-1 Priority Program (SPP1926), SFB874 (B10) and SFB1200 (A07) (S.H.), and a KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas “Willdynamics” (16H06401) (T.S.).
The authors declare no competing financial interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Soya, S., Takahashi, T.M., McHugh, T.J. et al. Orexin modulates behavioral fear expression through the locus coeruleus. Nat Commun 8, 1606 (2017). https://doi.org/10.1038/s41467-017-01782-z
Orexin deficiency affects sociability and the acquisition, expression, and extinction of conditioned social fear
Brain Research (2021)
Journal of Alzheimer's Disease (2021)
Scientific Reports (2020)
Distinct temporal integration of noradrenaline signaling by astrocytic second messengers during vigilance
Nature Communications (2020)
Xiaoyaosan regulates depression‐related behaviors with physical symptoms by modulating Orexin A/OxR1 in the hypothalamus
The Anatomical Record (2020)